On Monday, ProntoForms reported its Q3, 2014 results. The company lost $313,260 on revenue of $1.69-million, up 48% over last year’s third quarter topline.
“We are pleased with our third quarter and our continuing trend of increasing overall revenue,” said CEO Alvaro Pombo. “More importantly, we now have 17 consecutive quarters of increasing our recurring revenue base. Our year-to-date total revenue (nine months) has increased 55 per cent, and recurring revenue has increased 50 per cent over the comparable period last year. We have good momentum, and we are prudently increasing our spending rate to take advantage of the increasing number of opportunities available to us.”
Leung notes that ProntoForms third quarter results bested his expectations for both revenue and EBITDA. He says the results were more evidence that the company is executing against its plan and that it is in an excellent position to grab market share in the nascent mobile forms space. He points out that ProntoForms has established strong relationships with the likes of AT&T, Nextel, Rogers and Bell, and also has an opportunity to upsell its existing customer base of more than 2500.
“Our Buy thesis,” says Leung, “is predicated on our positive view of the company’s near-term growth prospects given the high ROI and stickiness associated with its SaaS-based mobile forms solution, the low rate of market adoption, its strong channel partnership with leading mobile carriers, along with the desirability of the company’s customer base and platform as a potential takeout candidate.”
In a research update to clients this morning, Leung reiterated his “Buy” rating and $0.70 one-year target on ProntoForms, implying a return of 75% at the time of publication.
Research Capital analyst Greg McLeish said in a July 29 update that Cannara Biotech (Cannara Biotech Stock Quote, Chart, News,… [Read More]
Beacon Securities analyst Gabriel Leung noted in a July 30 report that Tantalus Systems (Tantalus Systems Holding Stock Quote, Chart,… [Read More]
Roth Capital Markets is initiating coverage of Sanuwave Health (Sanuwave Health Stock Quote, Chart, News, Analysts, Financials NASDAQ:SNWV) with a… [Read More]
Roth Capital Markets analyst Jason Wittes noted in a July 28 pre-IPO report that Shoulder Innovations, a new entrant in… [Read More]
Roth Capital Markets analyst Philip Shen said in a July 28 earnings preview that Nextracker (Nextracker Stock Quote, Chart, News,… [Read More]
Brian Madden, Chief Investment Officer at First Avenue Investment Counsel, said on BNN Bloomberg’s Market Call on July 25 that… [Read More]